A detailed history of Armstrong Henry H Associates Inc transactions in Medtronic PLC stock. As of the latest transaction made, Armstrong Henry H Associates Inc holds 138,329 shares of MDT stock, worth $11.9 Million. This represents 1.2% of its overall portfolio holdings.

Number of Shares
138,329
Previous 146,703 5.71%
Holding current value
$11.9 Million
Previous $11.5 Million 7.86%
% of portfolio
1.2%
Previous 1.16%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 02, 2024

SELL
$76.84 - $91.03 $643,458 - $762,285
-8,374 Reduced 5.71%
138,329 $12.5 Million
Q2 2024

Jul 02, 2024

SELL
$78.71 - $87.02 $300,672 - $332,416
-3,820 Reduced 2.54%
146,703 $11.5 Million
Q1 2024

Apr 11, 2024

SELL
$82.84 - $88.09 $75,798 - $80,602
-915 Reduced 0.6%
150,523 $13.1 Million
Q4 2023

Jan 10, 2024

SELL
$69.43 - $83.43 $1.45 Million - $1.74 Million
-20,835 Reduced 12.09%
151,438 $12.5 Million
Q3 2023

Oct 16, 2023

SELL
$78.22 - $90.4 $409,012 - $472,701
-5,229 Reduced 2.95%
172,273 $13.5 Million
Q2 2023

Jul 10, 2023

SELL
$79.47 - $91.38 $915,335 - $1.05 Million
-11,518 Reduced 6.09%
177,502 $15.6 Million
Q1 2023

Apr 12, 2023

SELL
$76.72 - $87.58 $1.24 Million - $1.41 Million
-16,143 Reduced 7.87%
189,020 $15.2 Million
Q4 2022

Jul 10, 2023

BUY
$76.18 - $87.74 $1.23 Million - $1.42 Million
16,143 Added 8.54%
205,163 $15.9 Million
Q4 2022

Jan 09, 2023

SELL
$76.18 - $87.74 $438,187 - $504,680
-5,752 Reduced 2.73%
205,163 $15.9 Million
Q3 2022

Oct 12, 2022

BUY
$80.75 - $95.31 $29,231 - $34,502
362 Added 0.17%
210,915 $17 Million
Q2 2022

Jul 13, 2022

BUY
$87.4 - $113.09 $22,024 - $28,498
252 Added 0.12%
210,553 $18.9 Million
Q1 2022

Apr 27, 2022

SELL
$100.58 - $112.38 $175,512 - $196,103
-1,745 Reduced 0.82%
210,301 $23.3 Million
Q4 2021

Jan 20, 2022

SELL
$99.53 - $127.75 $241,061 - $309,410
-2,422 Reduced 1.13%
212,046 $21.9 Million
Q3 2021

Oct 26, 2021

SELL
$122.75 - $135.17 $13,993 - $15,409
-114 Reduced 0.05%
214,468 $26.9 Million
Q2 2021

Jul 20, 2021

SELL
$118.19 - $131.5 $115,826 - $128,870
-980 Reduced 0.45%
214,582 $26.6 Million
Q1 2021

Apr 20, 2021

SELL
$111.18 - $119.74 $2,334 - $2,514
-21 Reduced 0.01%
215,562 $25.5 Million
Q4 2020

Feb 01, 2021

BUY
$100.57 - $117.14 $208,783 - $243,182
2,076 Added 0.97%
215,583 $25.3 Million
Q3 2020

Oct 26, 2020

SELL
$90.13 - $108.78 $192,788 - $232,680
-2,139 Reduced 0.99%
213,507 $22.2 Million
Q2 2020

Jul 22, 2020

SELL
$84.11 - $103.33 $242,909 - $298,417
-2,888 Reduced 1.32%
215,646 $19.8 Million
Q1 2020

May 05, 2020

BUY
$72.92 - $121.3 $195,133 - $324,598
2,676 Added 1.24%
218,534 $19.7 Million
Q4 2019

Jan 29, 2020

BUY
$104.49 - $114.54 $176,588 - $193,572
1,690 Added 0.79%
215,858 $24.5 Million
Q3 2019

Oct 16, 2019

BUY
$98.02 - $111.18 $155,361 - $176,220
1,585 Added 0.75%
214,168 $23.3 Million
Q2 2019

Jul 19, 2019

SELL
$84.15 - $99.38 $1.96 Million - $2.31 Million
-23,280 Reduced 9.87%
212,583 $20.7 Million
Q1 2019

Apr 16, 2019

BUY
$82.45 - $93.79 $296,490 - $337,268
3,596 Added 1.55%
235,863 $21.5 Million
Q4 2018

Jan 28, 2019

BUY
$85.8 - $99.49 $1.29 Million - $1.49 Million
15,005 Added 6.91%
232,267 $21.1 Million
Q3 2018

Oct 19, 2018

BUY
$85.91 - $99.17 $862,965 - $996,162
10,045 Added 4.85%
217,262 $21.4 Million
Q2 2018

Jul 25, 2018

BUY
$77.48 - $87.83 $200,285 - $227,040
2,585 Added 1.26%
207,217 $17.7 Million
Q1 2018

Apr 30, 2018

BUY
$76.55 - $87.26 $749,807 - $854,711
9,795 Added 5.03%
204,632 $16.5 Million
Q4 2017

Jan 23, 2018

BUY
$76.93 - $83.5 $790,840 - $858,380
10,280 Added 5.57%
194,837 $15.7 Million
Q3 2017

Oct 24, 2017

BUY
$77.71 - $84.6 $14.3 Million - $15.6 Million
184,557
184,557 $14.4 Million

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $114B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Armstrong Henry H Associates Inc Portfolio

Follow Armstrong Henry H Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armstrong Henry H Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Armstrong Henry H Associates Inc with notifications on news.